5 SIMPLE STATEMENTS ABOUT LDN-27219 CLINICAL TRIALS EXPLAINED

In distinction to neurodegerative disorders and cancer, the contribution of TG2 activity to celiac sprue pathogenesis has been rather perfectly established. The deamidation of specific glutamine residues targeted by TG2 in gluten peptides has been shown to improve peptide binding into the disease-associated proteins HLA-DQ2/eight, which might be th